All Roads Lead to Change: Addressing Unmet Needs in the African American MS Community

Best Practices in Improving Care Quality and Mitigating Health Disparities from the Multiple Sclerosis Association of America Working Group


Expert Working Group Members

Mitzi Joi Williams, MD                                     
Joi Life Wellness Group, LLC
Click here for biography

Oluwasheyi Akin Ayeni, MD
Clinical Neurologist
Kaiser Permanente

Angala B. Borders-Robinson, DO, FACN
Clinical Neurologist
Noran Neurological Clinic

Heidi Crayton, MD
Clinical Neurologist
MS Center of Greater Washington

Jacqueline Faulkner Rosenthal, MD
Clinical Neurologist
Shepherd Center

Tirisham Gyang, MD
Assistant Clinical Professor
University of Florida College of Medicine

Annette Howard, MD
Medical Director
MS Institute of Texas

Angela Lang Chandler, MD
Clinical Neurologist
Baptist Neurosciences

Annette Okai, MD
Medical Director
MS Treatment Center of Dallas
Baylor University Medical Center

Yolanda Smith Wheeler, PhD, CRNP, CPNP-AC, MSCN
Assistant Professor, UAB School of Nursing
Pediatric Acute Care Nurse Practitioner, UAB Center for Pediatric Onset Demyelinating Disease

Aljoeson Walker, MD
Clinical Neurologist
Medical University of South Carolina

Sophia D. Woodson, CNP
Neurology Nurse Practitioner
UH Cleveland Medical Center

Target Audience
This activity is designed to meet the educational needs of a broad audience of health care providers including pharmacy directors, clinical pharmacists, specialty pharmacists, neurologists, primary care providers, registered nurses, ER providers, social workers, and case managers involved in the treatment and management of Black patients with MS.

Statement of Need/Program Overview 
This activity will provide content direction and recommendations for a set of multifaceted interventions to improve the knowledge and performance of MS clinicians that are currently treating, or have the potential to treat, African American MS patients. The anticipated result of these interventions is to better identify and detect early signs of disease progression, along with appropriate and timely therapeutic intervention for the African American MS patient population.

Educational Objectives 

ACCREDITATION INFORMATION

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, Multiple Sclerosis Association of America, and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hours (0.125 CEU) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-21-2618-H01-P
Type of Activity: Knowledge

Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Social Work Education

As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.  Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 cultural competency continuing education credits.

Case Manager Continuing Education
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1 CE contact hour(s). Activity code: H00045084  Approval Number: 210000452

To claim these CEs, log into your CCMC Dashboard at www.ccmcertification.org.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Name of Working Group Members/Planners

Reported Financial Relationship

Mitzi Joi Williams, MD

Consulting fees (ex. advisory boards) - Novartis, Biogen, EMD Serono, AbbVie, Genzyme, Bristol Meyers Squibb, Alexion
Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus) - Novartis, Biogen, EMD Serono, AbbVie, Genzyme, Bristol Meyers Squibb, TEVA

Oluwasheyi Akin Ayeni, MD

Oluwasheyi Akin Ayeni, MD has nothing to disclose.

Annette Howard, MD

Consulting fees (ex.advisory boards): EMD Serono, Bristol Myers Squibb, Sanofi Genzyme
Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): EMD Serono, Bristol Myers Squibb, Sanofi Genzyme

Annette Okai, MD

Consulting fees (ex.advisory boards): Sanofi Genzyme, Genentech, Biogen, Novartis, EMD Serono
Contracted Research: Sanofi Genzyme, Genentech, Biogen

Angala B. Borders-Robinson, DO, FACN

Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): Novartis, Sanofi Genzyme, Genentech

Jacqueline Faulkner Rosenthal, MD

Consulting fees (ex.advisory boards): Genentech

Aljoeson Walker, MD

Consulting fees (ex.advisory boards): Biogen
Ownership Interest less than 5%: Pfizer

Yolanda Smith Wheeler, PhD, RNP, CPNP-AC, MSCN

Salary: National MS Society
Consulting fees (ex.advisory boards): African American Advisory Board for the MSAA; Bafiertan Nurse Virtual Advisory Board for Banner Life Sciences

Tirisham Gyang, MD

Consulting fees (ex.advisory boards):EMD Serono, Genentech
Contracted Research: Sanofi

Sophia D. Woodson, CNP

Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): Biogen, Genentech, Novartis

Heidi Crayton, MD

Consulting fees (ex.advisory boards): Biogen, Bristol Myers Squibb, EMD Serono, Roche
Contracted Research: Biogen, Novartis, Roche

Angela Lang Chandler, MD

Consulting fees (ex.advisory boards) – National MS Society, SK Life Science
Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): SK Life Sciences, Sanofi Genzyme, Teva

The PIM planners and managers have nothing to disclose.
The MSAA planners and managers have nothing to disclose.
The Impact Education, LLC® planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period of accreditation participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, a certificate will be made available immediately to download and print.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account. Credit must be uploaded to CPE Monitor within 30 days.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.